Search Results - O’Shaughnessy, Joyce

Refine Results
  1. 1
    A decade of letrozole: FACE

    A decade of letrozole: FACE by O’Shaughnessy, Joyce

    Published 2007
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    A decade of letrozole: FACE

    A decade of letrozole: FACE by O’Shaughnessy, Joyce

    Published 2008
    Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Treatment options for patients with HR+/HER2− advanced breast cancer during the COVID-19 pandemic: dose reduction of ribociclib does not diminish efficacy

    Treatment options for patients with HR+/HER2− advanced breast cancer during the COVID-19 pandemic: dose reduction of ribociclib does not diminish efficacy by O’Shaughnessy, Joyce

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    PARP as a novel therapeutic target in cancer

    PARP as a novel therapeutic target in cancer by Annunziata, Christina M., O’Shaughnessy, Joyce

    Published 2010
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    The hedgehog pathway in triple‐negative breast cancer

    The hedgehog pathway in triple‐negative breast cancer by Habib, Joyce G., O'Shaughnessy, Joyce A.

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    Dendritic Cells, Inflammation and Breast Cancer

    Dendritic Cells, Inflammation and Breast Cancer by Palucka, Karolina, Coussens, Lisa M., O’Shaughnessy, Joyce

    Published 2013
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    nab-Paclitaxel for first-line treatment of patients with metastatic breast cancer and poor prognostic factors: a retrospective analysis

    nab-Paclitaxel for first-line treatment of patients with metastatic breast cancer and poor prognostic factors: a retrospective analysis by O’Shaughnessy, Joyce, Gradishar, William J., Bhar, Paul, Iglesias, Jose

    Published 2013
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    Highlights of the 2015 San Antonio Breast Cancer Symposium

    Highlights of the 2015 San Antonio Breast Cancer Symposium by Keaton, Mark, Tripathy, Debu, O'Shaughnessy, Joyce, Tang, Shou-Ching

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    Prevalence of germline BRCA mutations in HER2-negative metastatic breast cancer: global results from the real-world, observational BREAKOUT study

    Prevalence of germline BRCA mutations in HER2-negative metastatic breast cancer: global results from the real-world, observational BREAKOUT study by O’Shaughnessy, Joyce, Brezden-Masley, Christine, Cazzaniga, Marina, Dalvi, Tapashi, Walker, Graham, Bennett, James, Ohsumi, Shozo

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    A multidisciplinary approach to optimizing care of patients treated with alpelisib

    A multidisciplinary approach to optimizing care of patients treated with alpelisib by Rugo, Hope S., Lacouture, Mario E., Goncalves, Marcus D., Masharani, Umesh, Aapro, Matti S., O'Shaughnessy, Joyce A.

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  11. 11
    Capecitabine Monotherapy: Review of Studies in First-Line HER-2-Negative Metastatic Breast Cancer

    Capecitabine Monotherapy: Review of Studies in First-Line HER-2-Negative Metastatic Breast Cancer by O'Shaughnessy, Joyce A., Kaufmann, Manfred, Siedentopf, Friederike, Dalivoust, Philippe, Debled, Marc, Robert, Nicholas J., Harbeck, Nadia

    Published 2012
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  12. 12
    Economic and Humanistic Burden of Triple-Negative Breast Cancer: A Systematic Literature Review

    Economic and Humanistic Burden of Triple-Negative Breast Cancer: A Systematic Literature Review by Huang, Min, Haiderali, Amin, Fox, Grace E., Frederickson, Andrew, Cortes, Javier, Fasching, Peter A., O’Shaughnessy, Joyce

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  13. 13
    Impact of prior anthracycline or taxane use on eribulin effectiveness as first-line treatment for metastatic breast cancer: results from two phase 2, multicenter, single-arm studies

    Impact of prior anthracycline or taxane use on eribulin effectiveness as first-line treatment for metastatic breast cancer: results from two phase 2, multicenter, single-arm studie... by O’Shaughnessy, Joyce, McIntyre, Kristi, Schwartzberg, Lee, Wilks, Sharon, Puhalla, Shannon, Berrak, Erhan, Song, James, Vahdat, Linda

    Published 2015
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  14. 14
    Clinical effects of prior trastuzumab on combination eribulin mesylate plus trastuzumab as first-line treatment for human epidermal growth factor receptor 2 positive locally recurrent or metastatic breast cancer: results from a Phase II, single-arm, multicenter study

    Clinical effects of prior trastuzumab on combination eribulin mesylate plus trastuzumab as first-line treatment for human epidermal growth factor receptor 2 positive locally recurr... by Puhalla, Shannon, Wilks, Sharon, Brufsky, Adam M, O’Shaughnessy, Joyce, Schwartzberg, Lee S, Berrak, Erhan, Song, James, Vahdat, Linda

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  15. 15
    Health-related quality of life in patients receiving first-line eribulin mesylate with or without trastuzumab for locally recurrent or metastatic breast cancer

    Health-related quality of life in patients receiving first-line eribulin mesylate with or without trastuzumab for locally recurrent or metastatic breast cancer by Schwartzberg, Lee, McIntyre, Kristi, Wilks, Sharon, Puhalla, Shannon, O’Shaughnessy, Joyce, Berrak, Erhan, He, Yaohua, Vahdat, Linda

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  16. 16
    Efficacy of eribulin for metastatic breast cancer based on localization of specific secondary metastases: a post hoc analysis

    Efficacy of eribulin for metastatic breast cancer based on localization of specific secondary metastases: a post hoc analysis by O’Shaughnessy, Joyce, Cortes, Javier, Twelves, Chris, Goldstein, Lori J., Alexis, Karenza, Xie, Ran, Barrios, Carlos, Ueno, Takayuki

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  17. 17
    Phase 2 study of eribulin mesylate as first-line therapy for locally recurrent or metastatic human epidermal growth factor receptor 2-negative breast cancer

    Phase 2 study of eribulin mesylate as first-line therapy for locally recurrent or metastatic human epidermal growth factor receptor 2-negative breast cancer by McIntyre, Kristi, O’Shaughnessy, Joyce, Schwartzberg, Lee, Glück, Stefan, Berrak, Erhan, Song, James X., Cox, David, Vahdat, Linda T.

    Published 2014
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  18. 18
    A multicenter trial evaluating retaspimycin HCL (IPI-504) plus trastuzumab in patients with advanced or metastatic HER2-positive breast cancer

    A multicenter trial evaluating retaspimycin HCL (IPI-504) plus trastuzumab in patients with advanced or metastatic HER2-positive breast cancer by Modi, Shanu, Saura, Cristina, Henderson, Charles, Lin, Nancy U., Mahtani, Reshma, Goddard, Jill, Rodenas, Eduardo, Hudis, Clifford, O’Shaughnessy, Joyce, Baselga, Jose

    Published 2013
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  19. 19
    Eribulin Monotherapy in Patients Aged 70 Years and Older With Metastatic Breast Cancer

    Eribulin Monotherapy in Patients Aged 70 Years and Older With Metastatic Breast Cancer by Muss, Hyman, Cortes, Javier, Vahdat, Linda T., Cardoso, Fatima, Twelves, Chris, Wanders, Jantien, Dutcus, Corina E., Yang, Jay, Seegobin, Seth, O’Shaughnessy, Joyce

    Published 2014
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  20. 20
    Efficacy and Safety of Weekly Paclitaxel With or Without Oral Alisertib in Patients With Metastatic Breast Cancer: A Randomized Clinical Trial

    Efficacy and Safety of Weekly Paclitaxel With or Without Oral Alisertib in Patients With Metastatic Breast Cancer: A Randomized Clinical Trial by O’Shaughnessy, Joyce, McIntyre, Kristi, Wilks, Sharon, Ma, Ling, Block, Margaret, Andorsky, David, Danso, Michael, Locke, Tracy, Scales, Amy, Wang, Yunfei

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: